1st Quarter - Report

LIFE TECHNOLOGIES CORPORATION for LIFE TECHNOLOGIES CORPORATION

Firm
Client
Income
—
Expenses
$310,000
Expense method
A: Lobbying Disclosure Act definitions

What was lobbied

3 issue areas, each in the filer's own words, with who lobbied on it and where.

Copyright/Patent/Trademark CPT

HR 1260/S 515: PATENT REFORM ACT OF 2009; DAMAGES; POST GRANT; PATENT AND TRADEMARK OFFICE REFORMS; INEQUITBALE CONDUCT

LobbyistCovered position, as disclosed
JANET LYNCH LAMBERT N/A

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Bills named: H.R. 1260 (111th)

Health Issues HCR

HR 1: AMERICAN RECOVERY AND REINVESTMENT ACT, 2009; NATIONAL INSTITUTES OF HEALTH FUNDING, COMPARATIVE EFFECTIVENESS; NET OPERATING LOSSES TAX PROVISIONS HR 1548: PATHWAY FOR BIOSIMILARS ACT; CREATING A PATHWAY FOR BIOSIMILARS INCLUDING CLINICAL TESTING; NO MANDATORY SUBSTITUTION AT PHARMACY; NEED FOR DIFFERENT NAMES BILL NOT YET INTRODUCED: GENOMICS AND PERSONALIZED MEDICINE ACT; INCENTIVES FOR PERSONALIZED MEDICINE

LobbyistCovered position, as disclosed
JANET LYNCH LAMBERT N/A

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Bills named: H.R. 1548 (111th), H.R. 1 (111th)

Budget/Appropriations BUD

HR 1: AMERICAN RECOVERY AND REINVESTMENT ACT, 2009; NATIONAL INSTITUTES OF HEALTH FUNDING, COMPARATIVE EFFECTIVENESS; NET OPERATING LOSS TAX PROVISIONS BILL NOT YET INTRODUCED: JUSTICE DEPARTMENT APPROPRIATIONS ACT; FUNDING FOR THE DEBBIE SMITH REAUTHORIZATION ACT OF 2008 HR 1105: APPROPRIATIONS ACT, 2009; NATIONAL INSTITUTES OF HEALTH FUNDING; BIODEFENSE FUNDING

LobbyistCovered position, as disclosed
JANET LYNCH LAMBERT N/A

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Bills named: H.R. 1 (111th), H.R. 1105 (111th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.